{"id":4676,"date":"2025-05-21T19:01:35","date_gmt":"2025-05-21T19:01:35","guid":{"rendered":"https:\/\/neoplas-med.eu\/en\/?p=4676"},"modified":"2025-11-02T19:03:26","modified_gmt":"2025-11-02T19:03:26","slug":"neoplas-med-featured-in-the-venture-capital-magazine","status":"publish","type":"post","link":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/","title":{"rendered":"Neoplas Med featured in the Venture Capital Magazine"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-4677\" src=\"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai.jpg\" alt=\"\" width=\"2048\" height=\"1321\" srcset=\"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai.jpg 2048w, https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai-768x495.jpg 768w, https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai-1536x991.jpg 1536w, https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai-1400x903.jpg 1400w, https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai-600x387.jpg 600w, https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai-775x500.jpg 775w, https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai-500x323.jpg 500w, https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai-1320x851.jpg 1320w\" sizes=\"auto, (max-width: 706px) 89vw, (max-width: 767px) 82vw, 740px\" \/><\/p>\n<p><strong>Our unique precision technology, combined with scientific excellence, defines our core strength\u2019 explains Ulrike Sailer in the latest Impact Life Sciences issue by VentureCapital Magazin.<\/strong><\/p>\n<p>We are proud to see Neoplas Med featured as the pioneer in argon jet coldplasma therapy \u2013 operating from the heart of Greifswald\u2019s vibrant innovation ecosystem. As a leading force within the Jetplasma Cluster Greifswald and in close collaboration with leading research institutions and the University Hospital Center, we are perfectly positioned to bring cutting-edge medical technology from lab to clinic.<\/p>\n<p>Our flagship product, the argon cold plasma jet kINPen\u00ae MED, is the first clinically validated and MDR-certified device of its kind. Used in over 75% of university hospitals across the DACH region, with \u201clighthose\u201d clinics in Middle East and with more than 500,000 applications and 400+ studies, we are redefining the standard of wound care.<\/p>\n<p>Read the full article here: https:\/\/bc-production.pressmatrix.com\/de\/profiles\/98d522283e29\/editions\/4af93f1672d56defddac\/pages\/page\/9<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our unique precision technology, combined with scientific excellence, defines our core strength\u2019 explains Ulrike Sailer in the latest Impact Life Sciences issue by VentureCapital Magazin. We are proud to see Neoplas Med featured as the pioneer in argon jet coldplasma therapy \u2013 operating from the heart of Greifswald\u2019s vibrant innovation ecosystem. As a leading force &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Neoplas Med featured in the Venture Capital Magazine&#8221;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4676","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neoplas Med featured in the Venture Capital Magazine - neoplas med GmbH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neoplas Med featured in the Venture Capital Magazine - neoplas med GmbH\" \/>\n<meta property=\"og:description\" content=\"Our unique precision technology, combined with scientific excellence, defines our core strength\u2019 explains Ulrike Sailer in the latest Impact Life Sciences issue by VentureCapital Magazin. We are proud to see Neoplas Med featured as the pioneer in argon jet coldplasma therapy \u2013 operating from the heart of Greifswald\u2019s vibrant innovation ecosystem. As a leading force &hellip; Continue reading &quot;Neoplas Med featured in the Venture Capital Magazine&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/\" \/>\n<meta property=\"og:site_name\" content=\"neoplas med GmbH\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-21T19:01:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-02T19:03:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1321\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"kjurke\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"kjurke\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/\"},\"author\":{\"name\":\"kjurke\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#\\\/schema\\\/person\\\/e8b95ac434ef035faeed506d5c095277\"},\"headline\":\"Neoplas Med featured in the Venture Capital Magazine\",\"datePublished\":\"2025-05-21T19:01:35+00:00\",\"dateModified\":\"2025-11-02T19:03:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/\"},\"wordCount\":166,\"publisher\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/11\\\/NPM-in-der-Presse-Mai.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/\",\"url\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/\",\"name\":\"Neoplas Med featured in the Venture Capital Magazine - neoplas med GmbH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/11\\\/NPM-in-der-Presse-Mai.jpg\",\"datePublished\":\"2025-05-21T19:01:35+00:00\",\"dateModified\":\"2025-11-02T19:03:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/11\\\/NPM-in-der-Presse-Mai.jpg\",\"contentUrl\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2025\\\/11\\\/NPM-in-der-Presse-Mai.jpg\",\"width\":2048,\"height\":1321},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/neoplas-med-featured-in-the-venture-capital-magazine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neoplas Med featured in the Venture Capital Magazine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/\",\"name\":\"neoplas med GmbH\",\"description\":\"Die neoplas med GmbH entwickelt Medizintechnik f\u00fcr den Einsatz physikalischen Kaltplasmas f\u00fcr mehr Lebensqualit\u00e4t.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#organization\",\"name\":\"neoplas med GmbH\",\"url\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2021\\\/12\\\/cropped-logoNuMed.png\",\"contentUrl\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2021\\\/12\\\/cropped-logoNuMed.png\",\"width\":588,\"height\":250,\"caption\":\"neoplas med GmbH\"},\"image\":{\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/#\\\/schema\\\/person\\\/e8b95ac434ef035faeed506d5c095277\",\"name\":\"kjurke\",\"url\":\"https:\\\/\\\/neoplas-med.eu\\\/en\\\/news\\\/author\\\/kjurke\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neoplas Med featured in the Venture Capital Magazine - neoplas med GmbH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/","og_locale":"en_US","og_type":"article","og_title":"Neoplas Med featured in the Venture Capital Magazine - neoplas med GmbH","og_description":"Our unique precision technology, combined with scientific excellence, defines our core strength\u2019 explains Ulrike Sailer in the latest Impact Life Sciences issue by VentureCapital Magazin. We are proud to see Neoplas Med featured as the pioneer in argon jet coldplasma therapy \u2013 operating from the heart of Greifswald\u2019s vibrant innovation ecosystem. As a leading force &hellip; Continue reading \"Neoplas Med featured in the Venture Capital Magazine\"","og_url":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/","og_site_name":"neoplas med GmbH","article_published_time":"2025-05-21T19:01:35+00:00","article_modified_time":"2025-11-02T19:03:26+00:00","og_image":[{"width":2048,"height":1321,"url":"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai.jpg","type":"image\/jpeg"}],"author":"kjurke","twitter_card":"summary_large_image","twitter_misc":{"Written by":"kjurke","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/#article","isPartOf":{"@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/"},"author":{"name":"kjurke","@id":"https:\/\/neoplas-med.eu\/en\/#\/schema\/person\/e8b95ac434ef035faeed506d5c095277"},"headline":"Neoplas Med featured in the Venture Capital Magazine","datePublished":"2025-05-21T19:01:35+00:00","dateModified":"2025-11-02T19:03:26+00:00","mainEntityOfPage":{"@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/"},"wordCount":166,"publisher":{"@id":"https:\/\/neoplas-med.eu\/en\/#organization"},"image":{"@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/#primaryimage"},"thumbnailUrl":"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/","url":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/","name":"Neoplas Med featured in the Venture Capital Magazine - neoplas med GmbH","isPartOf":{"@id":"https:\/\/neoplas-med.eu\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/#primaryimage"},"image":{"@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/#primaryimage"},"thumbnailUrl":"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai.jpg","datePublished":"2025-05-21T19:01:35+00:00","dateModified":"2025-11-02T19:03:26+00:00","breadcrumb":{"@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/#primaryimage","url":"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai.jpg","contentUrl":"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2025\/11\/NPM-in-der-Presse-Mai.jpg","width":2048,"height":1321},{"@type":"BreadcrumbList","@id":"https:\/\/neoplas-med.eu\/en\/news\/neoplas-med-featured-in-the-venture-capital-magazine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoplas-med.eu\/en\/"},{"@type":"ListItem","position":2,"name":"Neoplas Med featured in the Venture Capital Magazine"}]},{"@type":"WebSite","@id":"https:\/\/neoplas-med.eu\/en\/#website","url":"https:\/\/neoplas-med.eu\/en\/","name":"neoplas med GmbH","description":"Die neoplas med GmbH entwickelt Medizintechnik f\u00fcr den Einsatz physikalischen Kaltplasmas f\u00fcr mehr Lebensqualit\u00e4t.","publisher":{"@id":"https:\/\/neoplas-med.eu\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoplas-med.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/neoplas-med.eu\/en\/#organization","name":"neoplas med GmbH","url":"https:\/\/neoplas-med.eu\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/neoplas-med.eu\/en\/#\/schema\/logo\/image\/","url":"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2021\/12\/cropped-logoNuMed.png","contentUrl":"https:\/\/neoplas-med.eu\/en\/wp-content\/uploads\/sites\/2\/2021\/12\/cropped-logoNuMed.png","width":588,"height":250,"caption":"neoplas med GmbH"},"image":{"@id":"https:\/\/neoplas-med.eu\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/neoplas-med.eu\/en\/#\/schema\/person\/e8b95ac434ef035faeed506d5c095277","name":"kjurke","url":"https:\/\/neoplas-med.eu\/en\/news\/author\/kjurke\/"}]}},"_links":{"self":[{"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/posts\/4676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/comments?post=4676"}],"version-history":[{"count":1,"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/posts\/4676\/revisions"}],"predecessor-version":[{"id":4678,"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/posts\/4676\/revisions\/4678"}],"wp:attachment":[{"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/media?parent=4676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/categories?post=4676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoplas-med.eu\/en\/wp-json\/wp\/v2\/tags?post=4676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}